Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.84
-0.43 (-3.01%)
At close: Apr 28, 2026, 4:00 PM EDT
13.37
-0.47 (-3.43%)
After-hours: Apr 28, 2026, 7:01 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.94 billion as of April 28, 2026. Its market cap has increased by 260.93% in one year.
Market Cap
1.94B
Enterprise Value
1.75B
1-Year Change
260.93%
Ranking
Category
Stock Price
$13.84
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.94B, an increase of 2,182.86%. That is a compound annual growth rate of 56.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 2.06B |
| Ocular Therapeutix | 2.03B |
| Mesoblast | 2.00B |
| Stoke Therapeutics | 1.97B |
| Capricor Therapeutics | 1.97B |
| Inhibrx Biosciences | 1.91B |
| AnaptysBio | 1.90B |
| Galapagos NV | 1.87B |